Get started

Bullish Trend Line

Paras Defence Price ActionParas Defence and Space Technologies is currently trading near ₹1,630, having delivered a substantial rally over the past year and outperformed many of its peers in the defence sector. The stock has risen more than 100% from its 52-week low and is trading close to its all-time high, reflecting strong investor confidence and robust momentum. Year-to-date, the stock is up over 60%, though it has shown some short-term volatility with a recent pullback of about 9% in just two days, suggesting a phase of consolidation or correction after its sharp rally. Fundamentally, the company has demonstrated impressive growth, with recent quarterly results showing revenue up nearly 36% year-on-year and net profit more than doubling. Its return on equity is healthy, and the business remains largely debt-free, which supports its financial stability. The company is also preparing for its first-ever stock split, with a record date set for July 4, 2025. This move is expected to enhance liquidity and attract more retail investors. Despite these positives, Paras Defence is trading at a high price-to-earnings ratio, indicating that the stock is priced for strong future growth and leaving little room for disappointment. Analyst sentiment is generally positive for the long term, but there is near-term caution due to the recent run-up in price and some signs of weakening momentum. Technical analysts point to key support levels around ₹1,500–₹1,570, with a need for the stock to reclaim ₹1,630 for renewed bullishness. Overall, Paras Defence is benefiting from strong sector tailwinds, government investment in defence, and its own technological capabilities. While the long-term outlook remains promising, investors should be mindful of the elevated valuation and the potential for further short-term corrections as the stock digests its recent gains.
NSE:PARASLong
by KamalKJoshi
Sudarshan Price ActionSudarshan Chemical Industries is currently trading around ₹1,256, having gained nearly 5% in the past week and over 6% in the last month. The stock has delivered a strong 10% return over six months and nearly 40% over the past year, reflecting robust momentum. Its 52-week high is ₹1,315, while the low stands at ₹796, placing the current price close to its yearly peak. Valuation-wise, Sudarshan Chemical trades at a high price-to-earnings ratio above 80 and a price-to-book ratio above 8, signaling that the stock is richly valued compared to sector norms. Despite the premium valuation, the company has attracted positive sentiment, with most analysts maintaining a buy or hold stance, though the average target price is slightly below current levels, suggesting limited near-term upside. Financially, the company has shown steady revenue growth and improved profitability in recent quarters, with net profit margins expanding from previous periods. However, promoter holding has decreased recently, and the company’s sales growth over the past year has been modest. The stock’s low beta indicates relatively lower volatility compared to the broader market. In summary, Sudarshan Chemical Industries is exhibiting strong price momentum and positive investor sentiment but is trading at expensive valuations. While its recent financial performance has improved, the high valuation and reduced promoter holding may warrant caution for new investors.
NSE:SUDARSCHEMLong
by KamalKJoshi
Infy Price actionInfosys (INFY) is currently trading around ₹1,608, with recent fluctuations between ₹1,606 and ₹1,629. Over the past year, the stock has delivered modest gains, slightly underperforming broader market indices and the IT sector. Financially, Infosys remains robust, maintaining strong revenues, healthy profit margins, and a debt-free balance sheet. The company continues to reward shareholders with consistent dividends, including a recent payout of ₹22 per share. Looking ahead, growth expectations for Infosys are muted. The company has projected revenue growth of just 0–3% for the upcoming fiscal year, citing macroeconomic uncertainties and cautious client spending in its key markets. This represents one of the lowest growth forecasts for Infosys in over a decade and reflects broader industry headwinds, including delayed client decision-making and a focus on cost optimization. Analyst sentiment is generally positive but cautious, with most maintaining a buy or hold rating. Price forecasts for the next year range from ₹1,667 to ₹1,945, indicating limited upside from current levels. Technical analysis shows immediate support near ₹1,579 and resistance around ₹1,633, suggesting the stock is likely to remain range-bound in the near term. In summary, Infosys is financially sound and offers stable dividends, but near-term growth is expected to be subdued due to global economic challenges and restrained client budgets. The stock is more attractive for investors seeking stability and income rather than aggressive capital appreciation at this stage.
NSE:INFYLong
by KamalKJoshi
OIL Price ActionOil India Limited is currently trading at ₹433.40 as of June 27, 2025. The stock has seen a notable decline over the past week, falling by nearly 7%. Over the last month, the price has remained relatively flat, with a slight gain of about 0.5%. Looking at a broader time frame, the stock is up 12% over the past three months and has gained just under 2% in the last six months. The 52-week high for Oil India stands at ₹767.90, while the low is ₹325.00, indicating that the stock is trading well below its peak for the year. Recent sessions have shown increased volatility, with sharp movements both up and down. For example, the stock dropped over 5% in a single day on June 24, after previously rallying above ₹470 earlier in the month. Oil India’s price-to-earnings (PE) ratio is 10.98, and the price-to-book (PB) ratio is 1.32, suggesting the stock is reasonably valued compared to its historical averages and sector peers. The company maintains a market capitalization of around ₹70,500 crore, ranking it among the larger players in India’s gas and petroleum sector. In summary, Oil India Limited is currently in a correction phase after a strong run-up earlier this year. The stock is trading closer to its recent lows than its highs, with moderate valuation metrics and ongoing volatility. Investors should watch for further price stabilization before considering new positions.
NSE:OILLong
by KamalKJoshi
KEC Price ActionKEC International’s share price as of June 6, 2025, is around ₹889.25, reflecting a 2.16% increase from the previous close. Over the past month, the stock has surged by 28.8%, and it is up 6.83% in the last week, showing strong short-term momentum. However, over the last six months, the stock is down by 26.85%, indicating significant volatility in the medium term . The company is currently trading at a price-to-earnings (P/E) ratio of 40.6 and a price-to-book (P/B) ratio of 4.33, both of which are considered high compared to the sector average P/E of 28.9. This suggests that the stock is priced at a premium relative to its peers . The dividend yield stands at 0.63% . KEC International recently secured new orders worth ₹2,211 crore across various segments, including Transmission & Distribution, Oil & Gas Pipelines, and Cables. This has contributed to a 40% year-to-date growth in orders and strengthened its international order book. As a result, analysts maintain a ‘Buy’ rating, with target prices ranging from ₹911 to ₹998, and some suggesting a potential 10% upside from current levels . Financially, the company’s trailing twelve-month earnings per share (EPS) has grown by 58.95% year-on-year, and the company has a market capitalization of about ₹23,295 crore . The stock hit its 52-week high at ₹1,313.25 and its 52-week low at ₹627.45, highlighting its volatility over the past year . In summary, KEC International is showing positive short-term momentum, backed by strong order inflows and optimistic analyst ratings. However, its high valuation multiples and recent volatility suggest that investors should approach with some caution, balancing growth prospects against the premium pricing and market fluctuations .
NSE:KECLong
by KamalKJoshi
Sobha Ltd's Price AnalysisSobha Ltd's share price as of late May 2025 is trading in the range of ₹1,349.60 to ₹1,386.10, with recent sessions showing minor fluctuations and a slight upward move from the previous close. Over the past year, the stock has declined by nearly 29%, though its longer-term performance remains strong, with a five-year return exceeding 600% . From a valuation perspective, Sobha is trading at a high price-to-earnings (P/E) ratio of about 225–241, which is significantly above the industry average and suggests the stock is priced for substantial future growth or that current earnings are relatively low. Its price-to-book (P/B) ratio is also elevated, at around 4.25–5.85 times, indicating a premium to its book value. The intrinsic value estimate is much lower than the current market price, at approximately ₹538.36, suggesting the stock is overvalued by fundamental metrics . Analyst sentiment remains largely positive, with about 76% of analysts recommending a buy and an average target price of ₹1,580.88, indicating a potential upside of around 15% from current levels. The highest analyst target is ₹2,459, while the lowest is ₹1,150, reflecting a wide range of expectations . Recent financial trends show revenue growth over the last three quarters, with net profit margins improving but still modest. Mutual fund holdings have slightly increased, and promoter holdings remain stable, both of which are generally positive indicators. However, the company has a low interest coverage ratio and has delivered poor sales growth over the past five years, signaling some underlying financial risks . Technically, the stock has shown short-term bearish signals, with a recent moving average crossover historically leading to declines in the following week. Despite this, the long-term outlook from analysts remains constructive, and historical data shows that Sobha has often delivered positive returns in May, with an average change of 6.85% for the month over 17 years . In summary, Sobha Ltd's stock is currently trading at a premium, with high valuations and mixed short-term signals, but it remains favored by analysts for its long-term growth potential. Investors should weigh the optimistic forecasts against the elevated risk implied by current valuations and recent negative momentum.
NSE:SOBHALong
by KamalKJoshi
Trident Ltd. Price Analysis (as of May 23, 2025)#### **Current Price and Recent Movement** - **Latest Price:** ₹32.11 (down 2.32% from the previous close) . - **1-Week Return:** +9.29% - **1-Month Return:** +9.11% - **1-Year Return:** -15.39% - **3-Year Return:** -32.89% #### **Technical Analysis** - **Buy Signal:** A 200-day moving average crossover occurred on May 21, 2025. Historically, this signal has led to an average gain of 6.61% within 30 days . - **Momentum Indicators:** - **RSI:** 62.17 (shows moderate bullish momentum) - **MACD:** 0.535 (bullish signal) - **Stochastic:** 75.40 (approaching overbought zone) - **Supertrend:** 26.03 (bullish) - **ROC:** 10.87 (positive momentum) - **Analyst Sentiment:** 100% of analysts currently recommend a "Buy" with an average target price of ₹38, indicating a potential upside of ~15.6% . #### **Fundamental Overview** - **P/E Ratio:** 44.50–45.65 (well below the industry average of 126.09, but still high relative to earnings growth) - **Price-to-Book Ratio:** 3.62–3.88 - **Dividend:** Announced ₹0.5 per share (record date: May 27, 2025) . - **Net Profit Margin:** 5.78% (FY24) - **Return on Equity:** 9.04% (FY24) - **Debt/Equity:** 0.48 (moderate leverage) - **Intrinsic Value Estimate:** ₹9.73 (suggests current price is at a premium to intrinsic value) #### **Recent Financial Performance** - **Q3 FY25 Revenue:** ₹1,667.09 crore (down 9.17% YoY) - **Profitability:** Net profit/share for FY24 was ₹0.76, down from ₹0.83 in FY23 - **Expense Management:** Interest expense is low at 1.86% of operating revenue; employee cost is 13.2% #### **Strengths** - Strong technical momentum and recent bullish crossover. - Consistent dividend payout. - Low interest expense and moderate leverage. #### **Weaknesses** - Declining revenue and profit over the last few quarters. - High valuation relative to earnings and intrinsic value. - Long-term returns have been negative over 1 and 3 years. #### **Outlook** Analysts remain bullish in the short term, buoyed by technical signals and an expected price target of ₹38 . However, fundamental concerns such as declining profits, high P/E, and premium to intrinsic value warrant caution for long-term investors. --- **Summary:** Trident Ltd. is showing short-term bullish momentum with positive technical indicators and analyst sentiment. However, investors should be cautious due to weak long-term performance, high valuation, and recent declines in revenue and profit .
NSE:TRIDENTLong
by KamalKJoshi
ASTRAL price action analysis Astral Ltd (ASTRAL) has shown a mix of volatility and recovery in May 2025. After a sharp decline earlier in the month, the stock rebounded, with recent prices moving from the ₹1,330–₹1,350 range up to ₹1,377.70 as of May 21, 2025. The trading volumes have remained strong, indicating active participation from both buyers and sellers. Technically, Astral is trading above its short-term volume-weighted average price (VWAP) of around ₹1,362.9, which is a positive sign for near-term momentum . The price action over the past week has included both sharp drops and quick recoveries, suggesting a tug-of-war between bulls and bears. Oscillators and moving averages currently indicate a neutral to mildly bullish setup, with the stock having recovered from oversold levels seen earlier in May. Astral’s 52-week high is ₹2,454, and the 52-week low is ₹1,232, showing that the current price is closer to the lower end of its yearly range . The price-to-earnings (P/E) ratio remains high (around 70), and the price-to-book (P/B) ratio is also elevated, reflecting premium valuations . The company’s fundamentals remain strong, but the high valuation and recent volatility suggest that further upside may require continued earnings growth or positive sector developments. In summary, Astral is currently in a recovery phase after recent volatility. The technical outlook is neutral to slightly positive as long as the stock holds above the VWAP and key short-term support levels. Investors should watch for sustained moves above ₹1,380–₹1,400 for confirmation of renewed bullish momentum, while a drop below ₹1,350 could signal renewed weakness.
NSE:ASTRALLong
by KamalKJoshi
## CreditAccess Grameen (CREDITACC) Share Price Analysis- As of May 2, 2025, CreditAccess Grameen (CREDITACC) traded around ₹1,121–₹1,145, which is approximately 52% above its 52-week low of ₹750.20 (set in January 2025), but below its 52-week high of ₹1,551.95 (set in June 2024) . - The stock has shown volatility over the past year, with a notable decline from its peak, reflecting both sector trends and company-specific events . **Valuation and Financial Metrics** - **P/E Ratio (TTM):** 20.3–21.2, indicating moderate valuation relative to earnings . - **Book Value:** ₹438 per share, with the stock trading at about 2.6 times book value, which is considered on the higher side for the sector . - **Dividend Yield:** Around 0.86–0.89%, with recent dividend payouts . - **Return on Equity (ROE):** 24.8% (latest year), reflecting strong profitability . - **Return on Capital Employed (ROCE):** 14.8% . **Growth and Profitability** - The company has delivered robust profit growth (35% CAGR over the last 5 years) and strong median sales growth (31.6% over 10 years) - However, profit growth has turned negative in the trailing twelve months (-35%), primarily due to higher provisioning and write-offs in recent quarters - The company reported a loss of ₹99.5 crore in Q3 FY25, mainly due to early risk recognition, conservative provisioning, and accelerated write-offs, but management expects this to safeguard future profitability as growth normalizes **Operational Highlights** - **Assets Under Management (AUM):** Grew by 6.1% YoY to ₹24,810 crore in Q3 FY25 - **Borrower Base:** Increased by 2.4% YoY to 48.05 lakh customers - **Branch Network:** Expanded by 8.7% YoY to 2,059 branches - **Collection Efficiency:** Remained robust at 93.3% (excluding arrears) and 94.1% (including arrears), with improving trends - **Asset Quality:** PAR 90+ at 2.64%, NNPA at 1.28%, indicating some stress but manageable levels - **Capital Adequacy:** CRAR at 25.9%, reflecting a strong capital position **Strengths and Risks** **Strengths:** - Consistent long-term growth in profits and sales - Strong capital position and liquidity buffer - High collection efficiency and expanding branch network **Risks/Concerns:** - Recent decline in promoter holding (-7.42% over three years) - Low interest coverage ratio, suggesting higher financial risk - Elevated provisioning and write-offs impacting near-term profitability - Stock is trading at a premium to book value, which may limit upside if growth slows **Relative Performance** - Over the past year, the stock is down 24%, underperforming the broader market, but over five years, it has delivered a 154% return, broadly in line with sector peers - In the short term (last three months), the stock has rebounded by about 13% from its lows ## Summary CreditAccess Grameen remains a leading NBFC-MFI with a strong track record of growth and profitability. While recent quarters have seen a dip in profits due to prudent risk management and provisioning, the company’s fundamentals-such as robust capital adequacy, liquidity, and operational scale-remain intact. The stock is moderately valued but carries risks related to asset quality and sector volatility. Investors should watch for normalization of growth and profitability in upcoming quarters, as indicated by management
NSE:CREDITACCLong
by KamalKJoshi
ERIS Lifesciences Share Price AnalysisEris Lifesciences is currently trading in the range of ₹1,371 to ₹1,474, with the latest reported price at ₹1,474.20 as of April 23, 2025. The stock has shown strong performance over the past year, delivering a return of approximately 57%. Over the last three months, the stock is up about 9%, though it has seen a slight dip of 0.57% in the past month. **Valuation and Fundamentals** Eris Lifesciences trades at a price-to-earnings (P/E) ratio of 57.13, which is high for the sector, and a price-to-book (P/B) ratio of 4.53. The company’s earnings per share (EPS) stands at 29.19, and its return on equity (ROE) is 12.63%, indicating moderate profitability. The market capitalization is approximately ₹18,831 crore . The dividend yield is negligible, suggesting the company focuses more on growth than on returning cash to shareholders. **Analyst Sentiment and Targets** Analyst sentiment is strongly positive, with nearly 89% recommending a buy and the remainder suggesting hold; there are no sell recommendations. The average long-term price target from analysts is ₹1,512.56, indicating modest upside from current levels. **Technical and Trading Overview** The stock has recently traded near its upper circuit of ₹1,659.60, with a lower circuit at ₹1,106.40, reflecting a relatively wide trading band and potential for volatility. Recent trading volumes have been healthy, supporting the current price momentum. **Summary** Eris Lifesciences has delivered strong returns over the past year and is viewed positively by analysts. However, its high P/E ratio suggests the stock is priced for continued growth, and the lack of dividend yield may not appeal to income-focused investors. The technical outlook is stable, with the stock trading near its highs and supported by robust trading activity.
NSE:ERISLong
by KamalKJoshi
### Maharashtra Seamless Ltd (MAHSEAMLES) Price Analysis #### **Current Price and Trends** - **Latest Price:** ₹704.55–₹736.85 (varies by source, reflecting intraday fluctuations) - **52-Week Range:** ₹562.65 – ₹964.35 - **Market Cap:** ₹9,143–₹9,149 crore #### **Recent Performance** - **Q3 FY25 Results:** - Revenue increased 2% YoY, driven by higher seamless pipe dispatches. - Profit declined due to lower treasury returns - **Order Book Stability:** ₹1,500–2,000 crore, supported by demand in oil/gas and manufacturing sectors #### **Technical Outlook** - **Risk Profile:** Moderate (2.72x volatility vs Nifty) - **Entry Point:** Stock appears underpriced with P/B and P/E ratios below sector averages #### **Strengths** 1. **Undervaluation:** P/E and P/B ratios are significantly lower than sector averages 2. **Dividend Consistency:** 1.47% yield, higher than sector average . 3. **Operational Resilience:** Stable order book and improved dispatches in Q3 FY25 #### **Weaknesses** 1. **Profit Decline:** PAT fell due to treasury returns and margin pressures 2. **Volatility:** Stock has seen significant price swings (52-week range: ~₹400 difference) ### Summary: Maharashtra Seamless shows **value potential** with attractive valuation ratios and stable demand in core sectors. However, recent profit declines and market volatility warrant caution. Investors should monitor quarterly earnings (next announcement: April 29, 2025) and global commodity trends.
NSE:MAHSEAMLESLong
by KamalKJoshi
ABBOTINDIA : CUP & HANDLE PATTERNAs I mentioned earlier, Don't Miss to catch this fish. The stock is currently moving up , after completing CUP n HANDLE Patter and taking support @ 22345.00 . Those who missed this stock earlier, the stock is providing a good opportunity to them again. The stock is at support , and at CMP i.e. 22733 is right time to enter the trade. for primary target of 24717.00 and we may see a new high thereafter. Currently this stock is with Low risk and high Reward and best stock to invest for the time being, with 20 EMA crossing over 50 EMA. This post is only for education purpose. Kindly trade at your own risk. Good Luck !!!
NSE:ABBOTINDIALong
by chakraveer1104
ASIAN PAINT LTD : BOTH SHORT AND LONG TERM TRADEAsian Paints Ltd does not need any introduction. With Market Cap of 2,69,000 Cr and a legacy of pre -independence foundation in 1945, the stock is all time favorite for for both retail and Institutional buyers. Currently the stock has just reversed from its downtrend and stands @ 2833.60. The chart has already tested the support @ 2820.10 which is our stop loss for this trade. One can enter this trade anytime now as it has crossed below the neck of reversed HEAD AND SHOULDER pattern . Out Targets would be 2913.50 , 3000 , 3254 and 3450 . It is both for short term trading as well as Long term hold as the stock is in uptrend in Higher Time frame ( Monthly ) RSI is crossing level of 50 in uptrend High Volume seen in recent trading days. We will definitely see Golden Cross over within next 3 weeks. A good opportunity to add this stock in your portfolio. Please keep boosting my study and analysis , it is helping me a lot. Good Lock !!!
NSE:ASIANPAINTLong
by chakraveer1104
2